Welcome
We are an interdisciplinary team advancing precision medicine in cardiometabolic disease. By uniting clinical expertise with cutting-edge science and innovation, we pioneer new strategies in inflammatory resolution, foster translational impact through humanized models and emerging technologies, and engage actively in public knowledge sharing.
Based at Steno Diabetes Center Aarhus, Aarhus University, and Sahlgrenska University Hospital,
we aim to transform patient care and global health.
Based at Steno Diabetes Center Aarhus, Aarhus University, and Sahlgrenska University Hospital,
we aim to transform patient care and global health.
Available Positions
We're always happy to hear from motivated candidates!
If you're interested in MSc, PhD or post-doc opportunities, feel free to get in touch. Active openings are posted below. Featured Work
Our review on the mechanisms of inflammation and its resolution in obesity published in Nature Reviews Endocrinology highlights emerging insights and therapeutic perspectives.
What inflammatory responses reveal about metabolic health
September 2026 We are pleased to share our new preprint exploring how the body’s response to an inflammatory challenge reveals differences in metabolic health across lean individuals and individuals with obesity. Using a skin blister model, we found that metabolically unhealthy individuals showed stronger early inflammatory responses, impaired resolution of inflammation and reduced tissue repair. These differences were more apparent in the local tissue response than in blood-based immune profiling, highlighting the importance of studying how inflammation develops and resolves over time. Thank you to all our collaborators and study participants for making this work possible! Read the preprint on bioRxiv. 
|
News SpotlightSeptember 2026: New preprint from the team on bioRxiv: Dynamic Responses to an Inflammatory Challenge Distinguish Metabolic Health Across Lean and Obese Individuals.
August 2026: Delighted to contribute to this new paper in Circulation: Heart Failure: Sex Differences in Skeletal Muscle Inflammation and Dysfunction in Patients With Heart Failure and Reduced Ejection Fraction. March 2026: New preprint from Madison Clark and the team on bioRxiv: Lipoxins Regulate Intercalated Disk-Associated Signaling and Immune Remodeling in Dilated Cardiomyopathy. June 2026: An eventful week! Now congratulations to Dr. Saeideh Tavajoh (MD, PhD) on successfully defending her PhD from the team. May 2026: Congratulations to Dr. Madison Clark (MSc, PhD) on successfully graduating with her PhD from the team. May 2026: Great science, great conversations, and great company at the annual SDCA Research Retreat. April 2026: Excited to share that we are part of MEDIculous REMeDy, a Marie Skłodowska-Curie PhD consortium. March 2026:Delighted to share updates on our research at the Inflammation Resolution meeting in Oslo. March 2026:New preprint from Madison Clark on bioRxiv: Lipoxins regulate intercalated disk–associated signaling and immune remodeling in dilated cardiomyopathy. 2026 March: We welcome our new students from the VIA University College, Rebekka Eriksen and Dina Toftgaard Sørensen 2026 February: Relaunching the PhD grant writing course #A330/02: an initiative from the AU Cardiovascular Network. 2026 January: Co-organized the 2025 I&I Annual Meeting at Legoland Resort, an engaging meeting featuring invited editors and a strong focus on student participation. 
The team at Steno Diabetes Centre Aarhus.
The team at Sahlgrenska Hospital, Sweden.
|
